Back

Asparagine-Rich Metastatic Niches Drive Prostate Cancer Organotropism By Enabling Translational Rewiring Toward N-Glycosylated Proteins

Pranzini, E.; Ippolito, L.; Iozzo, M.; Romagnoli, S.; Bertoli, G.; Venditti, G.; Lulli, M.; Santi, A.; Comito, G.; Polvani, S.; Lottini, T.; Benelli, M.; Scumaci, D.; Chiarugi, P.; Giannoni, E.

2026-03-02 cancer biology
10.64898/2026.02.27.708521 bioRxiv
Show abstract

Metastatic disease is the leading cause of mortality in prostate cancer (PC), with bone as the preferential site of dissemination and the lung frequently affected secondarily. Metabolic interactions between disseminated tumor cells and tissue-specific microenvironments play a key role in shaping site-specific metastatic patterns. In particular, the availability of certain metabolites before, during, and after the establishment of overt metastases represents a critical determinant of colonization. Here we show that asparagine (Asn) is selectively enriched in bone and lung microenvironments and supports PC metastatic colonization. Dietary Asn restriction selectively impairs bone and lung metastases in vivo, without affecting metastatic burden in other organs. Mechanistically, disseminated PC cells arriving at Asn-rich niches rely on extracellular Asn due to decreased asparagine synthetase (ASNS) expression enabling the activation of mTORC1-dependent translational program. Elevated Asn availability selectively promotes the synthesis of Asn-rich proteins enriched in N-glycosylation motifs (Asn-X-Ser/Thr), leading to enhanced global protein N-glycosylation during early metastatic colonization. This metabolic adaptation facilitates cell-cell interactions and promotes adhesion to bone- and lung-specific extracellular matrices. Among the N-glycosylated proteins induced by Asn, CD44 emerges as a central effector of PC bone metastases. Extracellular Asn shortening, genetic or pharmacological disruption N-glycosylation, or silencing of CD44 abolish the pro-metastatic advantage conferred by Asn. Together, these findings identify environmental Asn as a niche-specific metabolic cue that drives PC organotropism by rewiring translation toward proteins enriched in N-glycosylation sites, thereby enhancing adhesive interactions and revealing metabolic vulnerabilities that could be therapeutically exploited to interfere with earliest steps of metastatic colonization in PC.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 12%
14.0%
2
Cell Reports
1338 papers in training set
Top 4%
8.2%
3
Oncogene
76 papers in training set
Top 0.1%
7.0%
4
Cancer Discovery
61 papers in training set
Top 0.2%
6.7%
5
Molecular Cell
308 papers in training set
Top 3%
6.2%
6
Journal of Clinical Investigation
164 papers in training set
Top 0.6%
4.7%
7
Developmental Cell
168 papers in training set
Top 4%
4.7%
50% of probability mass above
8
Cancer Research
116 papers in training set
Top 0.6%
4.1%
9
eLife
5422 papers in training set
Top 27%
3.5%
10
Nature Cell Biology
99 papers in training set
Top 2%
2.5%
11
Advanced Science
249 papers in training set
Top 9%
2.0%
12
Science Advances
1098 papers in training set
Top 13%
2.0%
13
Cancer Cell
38 papers in training set
Top 0.9%
1.8%
14
Immunity
58 papers in training set
Top 2%
1.7%
15
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 33%
1.7%
16
Cell Metabolism
49 papers in training set
Top 1%
1.7%
17
Nature Cancer
35 papers in training set
Top 0.8%
1.7%
18
Cell
370 papers in training set
Top 12%
1.7%
19
The EMBO Journal
267 papers in training set
Top 2%
1.7%
20
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.6%
21
Journal of Cell Biology
333 papers in training set
Top 3%
1.3%
22
Nature Metabolism
56 papers in training set
Top 2%
1.3%
23
EMBO Molecular Medicine
85 papers in training set
Top 3%
1.2%
24
Nature
575 papers in training set
Top 13%
1.2%
25
Science
429 papers in training set
Top 17%
1.1%
26
Cell Chemical Biology
81 papers in training set
Top 3%
0.9%
27
JCI Insight
241 papers in training set
Top 7%
0.8%
28
Genome Medicine
154 papers in training set
Top 8%
0.7%
29
Cell Stem Cell
57 papers in training set
Top 2%
0.7%
30
Cell Reports Medicine
140 papers in training set
Top 10%
0.6%